Raymond James & Associates’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-165,324
| Closed | -$2.29M | – | 3955 |
|
2024
Q2 | $2.29M | Buy |
165,324
+1,155
| +0.7% | +$16K | ﹤0.01% | 2070 |
|
2024
Q1 | $3.07M | Buy |
164,169
+24,165
| +17% | +$452K | ﹤0.01% | 1895 |
|
2023
Q4 | $3.17M | Buy |
140,004
+55,428
| +66% | +$1.25M | ﹤0.01% | 1813 |
|
2023
Q3 | $2.1M | Buy |
+84,576
| New | +$2.1M | ﹤0.01% | 1988 |
|
2023
Q2 | – | Sell |
-21,387
| Closed | -$477K | – | 3784 |
|
2023
Q1 | $477K | Sell |
21,387
-36,467
| -63% | -$814K | ﹤0.01% | 2919 |
|
2022
Q4 | $1.54M | Sell |
57,854
-263
| -0.5% | -$6.99K | ﹤0.01% | 2167 |
|
2022
Q3 | $1.65M | Buy |
58,117
+12,955
| +29% | +$368K | ﹤0.01% | 2089 |
|
2022
Q2 | $941K | Sell |
45,162
-11,325
| -20% | -$236K | ﹤0.01% | 2479 |
|
2022
Q1 | $1.22M | Sell |
56,487
-900
| -2% | -$19.5K | ﹤0.01% | 2455 |
|
2021
Q4 | $1.59M | Buy |
+57,387
| New | +$1.59M | ﹤0.01% | 2317 |
|